Sarepta Therapeutics
0 sources
Financials
0001193125-26-084144Sarepta Therapeutics
Summary
Sarepta Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (302 views/month).[2]
Key Facts
- Sarepta Therapeutics's field of work was biopharmaceutical[3].
- Sarepta Therapeutics's field of work was rare disease[4].
- Sarepta Therapeutics's field of work was gene therapy[5].
- Sarepta Therapeutics is in the country of United States[6].
- Sarepta Therapeutics is in the country of US[7].
- Sarepta Therapeutics's instance of is recorded as business[8].
- Sarepta Therapeutics's instance of is recorded as public company[9].
- Sarepta Therapeutics's headquarters location is recorded as Cambridge[10].
- Sarepta Therapeutics's stock exchange is recorded as Nasdaq[11].
- Sarepta Therapeutics's industry is recorded as pharmaceutical industry[12].
- 1980 marks the founding of Sarepta Therapeutics[13].
- 2013-06-05 marks the founding of Sarepta Therapeutics[14].
- Sarepta Therapeutics's official website is recorded as http://www.sarepta.com/[15].
- Sarepta Therapeutics's legal form is recorded as Delaware corporation[16].
- Sarepta Therapeutics's legal form is recorded as XTIQ[17].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300IKDPIED8J8IG21[18]
-
Registered legal name: Sarepta Therapeutics, INC.[19]
-
Legal jurisdiction: US-DE[20]
-
GLEIF entity category: GENERAL[21]
-
Legal form (ISO 20275 ELF): XTIQ[22]
-
Entity status: ACTIVE[23]
-
LEI registration status: ISSUED[24]
-
Entity created: 2013-06-05[25]
-
LEI first registered: 2017-11-08[26]
-
LEI last updated: 2025-08-07[27]
-
LEI next renewal: 2026-08-07[28]
-
Managing LOU: 5493001KJTIIGC8Y1R12[29]
-
Registration authority: RA000602[30]
-
Authority entity ID: 5345340[31]
-
Other names: Avi BioPharma (Avii) (Srpt), Avi BioPharma, Inc.[32]
-
Conformity flag: CONFORMING[33]
Body
Founding
Recorded inception include 1980[13] and 2013-06-05[14].
Operations
Sarepta Therapeutics's headquarters location is recorded as Cambridge[10].
Industry
Sarepta Therapeutics's industry is recorded as pharmaceutical industry[12]. Fields of work include biopharmaceutical[3], a drug class[34]; rare disease[4], a disease attributes[35]; and gene therapy[5], a type of medical treatment[36].
Ownership
Sarepta Therapeutics's stock exchange is recorded as Nasdaq[11].
Why It Matters
Sarepta Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (302 views/month).[2] It is known by 4 alternative names across languages and contexts.[37]